IMPACT Therapeutics Announced ATR Inhibitor IMP9064 IND Clearance by USFDA.
SUMMARY: Impact Therapeutics is a biopharmaceutical company, announced that its ATR inhibitor IMP9064 has received the IND clearance from the US Food…
SUMMARY: Impact Therapeutics is a biopharmaceutical company, announced that its ATR inhibitor IMP9064 has received the IND clearance from the US Food…
Keypoints: PTC Therapeutics, Inc. announced that the Brazilian National Health Surveillance Agency has approved the expansion of the indication of Translarna (Ataluren)…
Neuland announces that The European Directorate for the Quality of Medicines & HealthCare (EDQM) recently granted a Certificate of Suitability (CEP) for Neuland’s API,…
Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the clinical trial of…
Synopsis– The chemotherapy has been developed from a molecule found in Himalayan caterpillar fungus and is still in the experimental testing stages. The…
The TYRVAYA nasal spray is the first approved nasal spray to treat dry eye disease. TYRVAYA nasal spray will benefit the patients…
Key Point – Aceto Pharma to acquire GMP of A&C Bio Buffer ltd Aceto will continue to support A&C BioBuffer’s manufacturing facilities and offices…